Literature DB >> 12428381

Thoracoscopic right upper mediastinal dissection for left lung cancer.

Katsunobu Kawahara1, Takeshi Shiraishi, Akinori Iwasaki, Yasuteru Yoshinaga, Satoshi Yamamoto, Satoshi Yoneda, Takayuki Shirakusa.   

Abstract

OBJECTIVE: In left lung cancer, left and right mediastinum lymphatic spread occur equally frequently. We evaluated the safety and effectiveness of thoracoscopic right upper mediastinal dissection, implemented prior to left lung resection for left lung cancer.
METHODS: Between January 1999 and May 2000, 17 patients with left lung cancer underwent thoracoscopic right upper mediastinal dissection prior to resection of the left lung and left mediastinal dissection for left lung cancer. These patients had either enlarged left hilar or bilateral mediastinal nodes, or either a tumor at least 3 cm in diameter or tumor extension to the hilum, mediastinum, or chest wall. Tumor and lymph nodes were examined with hematoxylin and eosin and immunohistochemical staining of cytokeratin for micrometastasis.
RESULTS: In 3 patients (17.6%), metastasis occurred in right paratracheal nodes. The 30-day mortality was 0% and morbidity 35.3% (6/17). Postoperative complications occurred in 3 of 4 patients (75%) undergoing induction chemotherapy, but none were lethal.
CONCLUSION: Thoracoscopic right upper mediastinal dissection is safe and feasible in treating advanced left lung cancer.

Entities:  

Mesh:

Year:  2002        PMID: 12428381     DOI: 10.1007/bf02913175

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  5 in total

Review 1.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.

Authors: 
Journal:  Crit Care Med       Date:  1992-06       Impact factor: 7.598

2.  Anatomical review of the lymph nodes of the human mediastinum.

Authors:  I Caplan
Journal:  Surg Radiol Anat       Date:  1990       Impact factor: 1.246

3.  Micrometastatic P53-positive cells in the lymph nodes of non-small-cell lung cancer: prognostic significance.

Authors:  K Dobashi; K Sugio; T Osaki; T Oka; K Yasumoto
Journal:  J Thorac Cardiovasc Surg       Date:  1997-09       Impact factor: 5.209

4.  Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma.

Authors:  Z L Chen; S Perez; E C Holmes; H J Wang; W F Coulson; D R Wen; A J Cochran
Journal:  J Natl Cancer Inst       Date:  1993-03-17       Impact factor: 13.506

5.  Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis.

Authors:  B Passlick; J R Izbicki; B Kubuschok; O Thetter; K Pantel
Journal:  Ann Thorac Surg       Date:  1996-01       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.